Tag: oncology
-
Uncertainties Surrounding the EU Joint Clinical Assessment: What do biotechs need to monitor
With the implementation of the new EU Health Technology Assessment (HTA) Regulation just four months away, uncertainties remain. The most important ones we will look at in this short clip, before exploring strategies for success the next time.
-
Nononsense EU JCA
No-nonsense EU HTA Introducing bit-sized no-nonsense insights about the EU HTA Regulation, Joint Clinical Assessment, Joint Scientific Consultations, etc etc. In a series of posts, there will be Q&A, process overviews, insights about preparedness, uncertainties and unknowns, as well as news as they happen in the continuing implementation phase. Got a question or query to…